Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human CacyBP ELISA Kit (AC2631)
Cat.#: ASET-1220
Specifications
Description Human CacyBP ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human CacyBP concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.17 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 125-2000 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1303 Mouse Neurotrophin 3 ELISA Kit (AC2714) Quantitative inquiry ASET-1596 Human PRAS40 ELISA Kit (AC3007) Quantitative inquiry ASET-1124 Human SOX3 ELISA Kit (AC2535) Quantitative inquiry ASET-2412 Human Pet1 ELISA Kit (AC3823) Quantitative inquiry ASET-2304 Mouse MEF2A ELISA Kit (AC3715) Quantitative inquiry ASET-1672 Human TMPRSS4 ELISA Kit (AC3083) Quantitative inquiry ASET-2234 Human Cx30 ELISA Kit (AC3645) Quantitative inquiry ASET-1776 Human Synapsin I ELISA Kit (AC3187) Quantitative inquiry ASET-2125 Mouse Heme Oxygenase 1 ELISA Kit (AC3536) Quantitative inquiry ASET-2147 Human SPOCK2 ELISA Kit (AC3558) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket